Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders
Till F. M. Andlauer, José Guzmán‐Parra, Fabian Streit, Jana Strohmaier, Maria José González, Susana Gil Flores, Francisco J. Cabaleiro Fabeiro, Francisco del Río Noriega, Fermín Pérez, Jesus Haro González, Guillermo Orozco Díaz, Yolanda de Diego‐Otero, Berta Moreno‐Küstner, Georg Auburger, Franziska Degenhardt, Stefanie Heilmann‐Heimbach, Stefan Herms, Per Hoffmann, Josef Frank, Jerome C. Foo, Jens Treutlein, Stephanie H. Witt, Sven Cichon, Manolis Kogevinas, Eli A. Stahl, Gerome Breen, Andreas J. Forstner, Andrew McQuillin, Stephan Ripke, Vassily Trubetskoy, Manuel Mattheisen, Yunpeng Wang, Jonathan R. I. Coleman, Héléna A. Gaspar, Christiaan de Leeuw, Stacy Steinberg, Jennifer M. Whitehead Pavlides, Maciej Trzaskowski, Tune H. Pers, Peter Holmans, Liam Abbott, Esben Agerbo, Huda Akil, Diego Albani, Ney Alliey‐Rodriguez, Thomas D. Als, Adebayo Anjorin, Verneri Antilla, Swapnil Awasthi, Judith A. Badner, Marie Bækvad‐Hansen, Jack D. Barchas, Nicholas Bass, Michael Bauer, Richard A. Belliveau, Sarah E. Bergen, Carsten Bøcker Pedersen, Erlend Bøen, Marco P. Boks, James Boocock, Monika Budde, William E. Bunney, Margit Burmeister, Jonas Bybjerg‐Grauholm, William Byerley, Miguel Casas, Felecia Cerrato, Pablo Cervantes, Kimberly Chambert, Alexander W. Charney, Danfeng Chen, Tracy Air, Toni‐Kim Clarke, William Coryell, David W. Craig, Cristiana Cruceanu, Piotr M. Czerski, Anders M. Dale, Simone de Jong, Jurgen Del‐Favero, J. Raymond DePaulo, Srdjan Djurovic, Amanda Dobbyn, Ashley Dumont, Torbjørn Elvsåshagen, Valentina Escott‐Price, Chun Chieh Fan, Sascha B Fischer, Matthew Flickinger, Tatiana Foroud, Liz Forty, Christine Fraser, Nelson B. Freimer, Louise Frisén, Katrin Gade, Diane Gage, Julie Garnham, Claudia GiambartolomeiMolecular2019 · DOI
Multiplex families with a high prevalence of a psychiatric disorder are often examined to identify rare genetic variants with large effect sizes. In the present study, we analysed whether the risk for bipolar disorder (BD) in BD multiplex families is influenced by common genetic variants. Furthermore, we investigated whether this risk is conferred mainly by BD-specific risk variants or by variants also associated with the susceptibility to schizophrenia or major depression. In total, 395 individuals from 33 Andalusian BD multiplex families (166 BD, 78 major depressive disorder, 151 unaffected) as well as 438 subjects from an independent, BD case/control cohort (161 unrelated BD, 277 unrelated controls) were analysed. Polygenic risk scores (PRS) for BD, schizophrenia (SCZ), and major depression were calculated and compared between the cohorts. Both the familial BD cases and unaffected family members had higher PRS for all three psychiatric disorders than the independent controls, with BD and SCZ being significant after correction for multiple testing, suggesting a high baseline risk for several psychiatric disorders in the families. Moreover, familial BD cases showed significantly higher BD PRS than unaffected family members and unrelated BD cases. A plausible hypothesis is that, in multiplex families with a general increase in risk for psychiatric disease, BD development is attributable to a high burden of common variants that confer a specific risk for BD. The present analyses demonstrated that common genetic risk variants for psychiatric disorders are likely to contribute to the high incidence of affective psychiatric disorders in the multiplex families. However, the PRS explained only part of the observed phenotypic variance, and rare variants might have also contributed to disease development.
Introduction: The Genetic Architecture of Multiplex Families
In psychiatric genetics, researchers typically distinguish between two types of risk factors: common variants, which are thousands of small-effect genetic tweaks prevalent in the general population, and rare variants, which are high-impact mutations found in few individuals. Multiplex families—those with an unusually high prevalence of a disorder like Bipolar Disorder (BD)—have traditionally been the primary focus for identifying rare, high-effect mutations. The prevailing assumption was that such a dense clustering of illness must be driven by a single, potent genetic "smoking gun."
However, recent research published in Molecular Psychiatry suggests a more complex reality. This study investigates whether the high incidence of BD in multiplex families might instead be driven by an extraordinary accumulation of common variants, effectively creating a "perfect storm" of genetic liability.
Methods: Quantifying Genetic Liability
The study utilized Polygenic Risk Scores (PRS) to quantify the cumulative effect of thousands of common genetic variants. To distinguish between general psychiatric liability and disorder-specific risk, the researchers employed Genome-Wide Inferred Statistics (GWIS). This allowed them to separate:
Shared Risk: Variants associated with BD, Schizophrenia (SCZ), and Major Depressive Disorder (MDD).
Disorder-Specific Risk: Variants unique to BD (e.g., BD risk adjusted for MDD risk).
The analysis compared 395 individuals from 33 Andalusian BD multiplex families (the ABiF study) against an independent cohort of 161 unrelated BD cases and 277 healthy controls. PRS models were trained using summary statistics from the Psychiatric Genomics Consortium (PGC). Negative controls, including PRS for Alzheimer’s disease and simulated random scores, were used to validate the specificity of the findings.
Key Results
The researchers found that members of multiplex families exist on a significantly higher "genetic plateau" of psychiatric risk compared to the general population.
Elevated Baseline Risk: Even unaffected members of these families carried higher PRS for BD and SCZ than healthy controls (Figure 4, Panels E and F). This suggests that the entire family lineage possesses a high baseline vulnerability to psychiatric disorders.
The Specific Trigger: While the whole family shared a high general risk, individuals who actually developed BD had significantly higher BD-specific PRS than their unaffected relatives. This indicates that while a general psychiatric burden is present, a specific accumulation of common BD variants pushes an individual over the diagnostic threshold.
Familial vs. Controls: Familial BD cases showed a massive increase in BD risk scores compared to controls (OR = 2.97, $p = 1.9 \times 10^{-11}$; Figure 4, Panel B) and significantly higher scores than unrelated BD patients who developed the disorder sporadically (Figure 4, Panel D).
Assortative Mating: Interestingly, "married-in" individuals (unrelated to the family by blood) also showed higher BD PRS than the general population. This suggests assortative mating, where individuals with high genetic liability for certain traits (e.g., creativity or emotional intensity) may be more likely to partner, further concentrating risk variants in subsequent generations.
Discussion and Future Directions
This study challenges the "rare variant only" paradigm for multiplex families. It demonstrates that common variants are a major, measurable component of the high disease burden in these families. However, the authors note that PRS only explains a fraction of the phenotypic variance.
While common variants set the stage, rare variants likely still play a critical role in disease development. Future research will focus on integrative models that combine PRS with whole-genome sequencing to map the full genetic landscape of high-density families. The current findings are limited by the specific geographic sample (Andalusia, Spain), and larger, more diverse datasets will be necessary to confirm these patterns globally.
Summary updated
Abstract
Multiplex families with a high prevalence of a psychiatric disorder are often examined to identify rare genetic variants with large effect sizes. In the present study, we analysed whether the risk for bipolar disorder (BD) in BD multiplex families is influenced by common genetic variants. Furthermore, we investigated whether this risk is conferred mainly by BD-specific risk variants or by variants also associated with the susceptibility to schizophrenia or major depression. In total, 395 individuals from 33 Andalusian BD multiplex families (166 BD, 78 major depressive disorder, 151 unaffected) as well as 438 subjects from an independent, BD case/control cohort (161 unrelated BD, 277 unrelated controls) were analysed. Polygenic risk scores (PRS) for BD, schizophrenia (SCZ), and major depression were calculated and compared between the cohorts. Both the familial BD cases and unaffected family members had higher PRS for all three psychiatric disorders than the independent controls, with BD and SCZ being significant after correction for multiple testing, suggesting a high baseline risk for several psychiatric disorders in the families. Moreover, familial BD cases showed significantly higher BD PRS than unaffected family members and unrelated BD cases. A plausible hypothesis is that, in multiplex families with a general increase in risk for psychiatric disease, BD development is attributable to a high burden of common variants that confer a specific risk for BD. The present analyses demonstrated that common genetic risk variants for psychiatric disorders are likely to contribute to the high incidence of affective psychiatric disorders in the multiplex families. However, the PRS explained only part of the observed phenotypic variance, and rare variants might have also contributed to disease development.
BibTeX
@inproceedings{andlauer2019bipolar,
author = {Till F. M. Andlauer and José Guzmán‐Parra and Fabian Streit and Jana Strohmaier and Maria José González and Susana Gil Flores and Francisco J. Cabaleiro Fabeiro and Francisco del Río Noriega and Fermín Pérez and Jesus Haro González and Guillermo Orozco Díaz and Yolanda de Diego‐Otero and Berta Moreno‐Küstner and Georg Auburger and Franziska Degenhardt and Stefanie Heilmann‐Heimbach and Stefan Herms and Per Hoffmann and Josef Frank and Jerome C. Foo and Jens Treutlein and Stephanie H. Witt and Sven Cichon and Manolis Kogevinas and Eli A. Stahl and Gerome Breen and Andreas J. Forstner and Andrew McQuillin and Stephan Ripke and Vassily Trubetskoy and Manuel Mattheisen and Yunpeng Wang and Jonathan R. I. Coleman and Héléna A. Gaspar and Christiaan de Leeuw and Stacy Steinberg and Jennifer M. Whitehead Pavlides and Maciej Trzaskowski and Tune H. Pers and Peter Holmans and Liam Abbott and Esben Agerbo and Huda Akil and Diego Albani and Ney Alliey‐Rodriguez and Thomas D. Als and Adebayo Anjorin and Verneri Antilla and Swapnil Awasthi and Judith A. Badner and Marie Bækvad‐Hansen and Jack D. Barchas and Nicholas Bass and Michael Bauer and Richard A. Belliveau and Sarah E. Bergen and Carsten Bøcker Pedersen and Erlend Bøen and Marco P. Boks and James Boocock and Monika Budde and William E. Bunney and Margit Burmeister and Jonas Bybjerg‐Grauholm and William Byerley and Miguel Casas and Felecia Cerrato and Pablo Cervantes and Kimberly Chambert and Alexander W. Charney and Danfeng Chen and Tracy Air and Toni‐Kim Clarke and William Coryell and David W. Craig and Cristiana Cruceanu and Piotr M. Czerski and Anders M. Dale and Simone de Jong and Franziska Degenhardt and Jurgen Del‐Favero and J. Raymond DePaulo and Srdjan Djurovic and Amanda Dobbyn and Ashley Dumont and Torbjørn Elvsåshagen and Valentina Escott‐Price and Chun Chieh Fan and Sascha B Fischer and Matthew Flickinger and Tatiana Foroud and Liz Forty and Josef Frank and Christine Fraser and Nelson B. Freimer and Louise Frisén and Katrin Gade and Diane Gage and Julie Garnham and Claudia Giambartolomei},
title = {{Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders}},
booktitle = {Molecular},
year = {2019},
doi = {10.1038/s41380-019-0558-2},
}